Cell line · CVCL_3172
SUIT-2
Cancer cell line, Homo sapiens. Pancreatic ductal adenocarcinoma. 45 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SUIT-2. Cell lines, record CVCL_3172. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3172
On this page
Cell line
As Cellosaurus gives it.
- Name
- SUIT-2
- Accession
- CVCL_3172
- RRID
- RRID:CVCL_3172
- Synonyms
- Suit-2, SUIT 2, SUIT2, Suit2, SUIzo Tumor-2
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 73Y
- Category
- Cancer cell line
- Diseases
- Pancreatic ductal adenocarcinoma (NCIt C9120)
- Derived from
- Liver (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers45
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chrysosplenetin-induced TMED3 aggregation triggers unfolded protein response in pancreatic cancer. | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma. | Cell Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sustained reductions in valine and isoleucine mediate anti-cancer pharmacological effects of inhibiting amino acid transporter LAT1 in cancer cells. | Cancer Metab | 2025 | Its Methods give the RRID and name the line | PubMed | |
| KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer. | Sci Adv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Stiff extracellular matrix activates the transcription factor ATF5 to promote the proliferation of cancer cells. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting KRAS-mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. | Cell Death Discov | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 45
See all 45 papersRelatives7
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | S2-007 | CVCL_B279 | Cell lines | |
| Derived from it | S2-013 | CVCL_B280 | Cell lines | |
| Derived from it | S2-020 | CVCL_B281 | Cell lines | |
| Derived from it | S2-028 | CVCL_B282 | Cell lines | |
| Derived from it | S2-CP8 | CVCL_F971 | Cell lines | |
| Derived from it | S2-VP10 | CVCL_F972 | Cell lines | |
| Derived from it | S2/TXT | CVCL_B283 | Cell lines |
Cell banks2
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| JCRB | JCRB1094 | JCRB | |
| TKG | TKG 0705 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3172
GET https://conductscience.org/api/cell-lines/v1/CVCL_3172/papers?page=2